home / stock / wllw:cc / wllw:cc quote
Last: | $0.13 |
---|---|
Change Percent: | -3.7% |
Open: | $0.135 |
Close: | $0.135 |
High: | $0.135 |
Low: | $0.12 |
Volume: | 951,874 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.13 | $0.135 | $0.135 | $0.135 | $0.12 | 951,874 | 08-02-2022 |
$0.22 | $0.23 | $0.22 | $0.23 | $0.215 | 243,791 | 05-06-2022 |
$0.245 | $0.25 | $0.245 | $0.25 | $0.235 | 211,406 | 05-05-2022 |
$0.245 | $0.25 | $0.245 | $0.255 | $0.235 | 195,980 | 05-04-2022 |
$0.24 | $0.24 | $0.24 | $0.25 | $0.23 | 287,823 | 05-03-2022 |
$0.26 | $0.265 | $0.26 | $0.28 | $0.26 | 56,519 | 05-02-2022 |
$0.25 | $0.285 | $0.25 | $0.29 | $0.25 | 143,907 | 04-29-2022 |
$0.28 | $0.285 | $0.28 | $0.285 | $0.28 | 14,893 | 04-28-2022 |
$0.285 | $0.285 | $0.285 | $0.295 | $0.285 | 53,504 | 04-27-2022 |
$0.29 | $0.3 | $0.29 | $0.3 | $0.28 | 226,069 | 04-26-2022 |
$0.31 | $0.315 | $0.31 | $0.315 | $0.31 | 27,125 | 04-25-2022 |
$0.32 | $0.33 | $0.32 | $0.33 | $0.31 | 139,297 | 04-22-2022 |
$0.335 | $0.35 | $0.335 | $0.35 | $0.33 | 180,539 | 04-21-2022 |
$0.335 | $0.36 | $0.335 | $0.36 | $0.335 | 151,359 | 04-20-2022 |
$0.365 | $0.35 | $0.365 | $0.365 | $0.35 | 27,061 | 04-19-2022 |
$0.36 | $0.365 | $0.36 | $0.365 | $0.35 | 256,356 | 04-18-2022 |
$0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 1,124 | 04-15-2022 |
$0.35 | $0.35 | $0.35 | $0.35 | $0.35 | 724 | 04-14-2022 |
$0.355 | $0.36 | $0.355 | $0.37 | $0.355 | 79,814 | 04-13-2022 |
$0.36 | $0.335 | $0.36 | $0.36 | $0.33 | 513,455 | 04-12-2022 |
News, Short Squeeze, Breakout and More Instantly...
Willow Biosciences Inc. Company Name:
WLLW:CC Stock Symbol:
TSXC Market:
Willow Biosciences Inc. Website:
WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITS Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ./ CALGARY, AB , July 18, 2024 /CNW/ - Willow Biosciences Inc. ...
WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM Canada NewsWire Company announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients Company anticipates ...
--News Direct-- Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share the company's plans to raise approximately $3 million. This capital will be used to support Willow Bioscience's recent partnership announcement with Laurus Labs. Dr. Savile explained tha...